已收盤 02-06 16:00:00 美东时间
+3.130
+2.19%
U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico Feb 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ametek, Coca-Cola and Pepsico, on Wednesday. HIGHLIGHTS * Ametek AME.N : RBC raises target price to $257 from $229 *
02-04 14:59
Popular Inc. Director Alejandro M. Ballester Reports Disposal of Common Shares Alejandro M. Ballester, Director of Popular Inc., reported a disposal of common shares of Popular Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies
02-03 00:04
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio Jan 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AGNC Investment, Brown & Brown and Korro Bio, on Thursday. HIGHLIGHTS * AGNC Investment Corp AGNC.O :
01-29 15:54
今日重点评级关注:Piper Sandler:维持Praxis Precision Medicine"超配"评级,目标价从450美元升至1200美元;Tigress Financial:维持Main International ETF"买入"评级,目标价从52美元升至66美元
01-29 11:06
Barclays analyst Jared Shaw maintains Popular (NASDAQ:BPOP) with a Overweight and raises the price target from $160 to $175.
01-28 20:29
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth Jan 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Boeing, Carvana and UnitedHealth on Wednesday. HIGHLIGHTS * Boeing BA.N : JP Morgan raises target price to $270
01-28 15:23
Popular Q4 profit rises on lower interest expenses Overview Financial services firm's Q4 net income rose to $233.9 mln from $211.3 mln in Q3 Q4 EPS increased to $3.53 from $3.15 in Q3 Company repurchased 1.25 mln shares for $147.8 mln in Q4 Result Drivers NET INTEREST INCOME - Higher net interest in
01-27 20:08
Popular (NASDAQ:BPOP) reported quarterly earnings of $3.53 per share which beat the analyst consensus estimate of $3.03 by 16.46 percent. This is a 40.64 percent increase over earnings of $2.51 per share from the same
01-27 20:02
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04